ASML Holding N.V. (LON:0M42)

Market Cap	214.20B
Revenue (ttm)	27.48B
Net Income (ttm)	8.04B
Shares Out	n/a
EPS (ttm)	20.52
PE Ratio	26.63
Forward PE	28.13
Dividend	4.65 (0.63%)
Ex-Dividend Date	Jul 29, 2025

Volume	5,044
Average Volume	10,220
Open	722.00
Previous Close	721.99
Day's Range	722.00 - 742.79
52-Week Range	561.02 - 949.38
Beta	n/a
RSI	56.77
Earnings Date	Jul 18, 2025

About Revance Therapeutics

ASML Holding N.V. provides lithography solutions for the development, production, marketing, sales, upgrading, and servicing of advanced semiconductor equipment systems. It offers lithography, metrology, and inspection systems. The company also provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography systems solutions to manufacture various range of semiconductor nodes and technologies. In addition, it offers metrology and inspection systems, including YieldStar optical ...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1984
• Employees: 42,786
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M42

Financial Performance

In 2024, ASML Holding's revenue was 28.26 billion, an increase of 2.56% compared to the previous year's 27.56 billion. Earnings were 7.57 billion, a decrease of -3.41%.